Canfosfamide is used in the research of malignant tumors; it acts as a glutathione analog prodrug that is activated by glutathione S-transferase P1-1 to induce apoptosis, and it also inhibits the catalytic kinase activity of DNA-dependent protein kinase (DNA-PK), generating an anticancer alkylating agent and a glutathione derivative upon activation.